Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310,871 | 118,420 | 99,107 | 35,227 | 256,739 |
| Receivables | 895,613 | 776,215 | 614,687 | 742,291 | 663,762 |
| Inventories | 606,302 | 612,454 | 581,384 | 530,735 | 489,389 |
| TOTAL | $1,911,181 | $1,587,806 | $1,377,863 | $1,411,818 | $1,520,108 |
| Non-Current Assets | |||||
| PPE Net | 442,950 | 424,908 | 447,574 | 469,815 | 514,158 |
| Intangibles | 1,158,968 | 1,329,813 | 1,489,052 | 1,694,946 | 1,759,939 |
| Other Non-Current Assets | 165,181 | 158,918 | 158,080 | 222,762 | 145,459 |
| TOTAL | $1,767,099 | $1,913,639 | $2,094,706 | $2,387,523 | $2,419,556 |
| Total Assets | $3,678,280 | $3,501,445 | $3,472,569 | $3,799,341 | $3,939,664 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,761 | 324,213 | 213,125 | 89,961 | 30,614 |
| Accounts payable and accrued liabilities | 816,801 | 757,761 | 541,983 | 540,678 | 573,206 |
| Other current liabilities | 43,256 | 31,755 | 76,988 | 107,483 | 58,000 |
| TOTAL | $881,633 | $1,129,771 | $846,595 | $752,800 | $677,243 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,565,115 | 2,161,790 | 2,427,451 | 2,631,687 | 2,718,091 |
| Other Non-Current Liabilities | 192,058 | 219,497 | 143,241 | 355,678 | 167,811 |
| TOTAL | $2,867,976 | $2,481,186 | $2,605,963 | $2,862,562 | $2,895,448 |
| Total Liabilities | $3,749,609 | $3,610,957 | $3,452,558 | $3,615,362 | $3,572,691 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 314,629 | 309,966 | 307,007 | 303,618 | 301,541 |
| Common Shares | 3,146 | 3,099 | 3,066 | 3,036 | 3,014 |
| Retained earnings | -535,005 | -607,062 | -490,176 | -406,183 | -276,197 |
| Other shareholders' equity | -111,264 | -65,755 | -32,119 | -104,503 | -18,194 |
| TOTAL | $-71,329 | $-109,512 | $20,011 | $183,979 | $366,973 |
| Total Liabilities And Equity | $3,678,280 | $3,501,445 | $3,472,569 | $3,799,341 | $3,939,664 |